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Background: Plasmodium falciparum shares its most recent common ancestor with parasites found in African apes;
these species constitute the so-called Laverania clade. In this investigation, the evolutionary history of Plasmodium
lineages found in chimpanzees (Pan troglodytes) was explored.
Methods: Here, the remainders of 74 blood samples collected as part of the chimpanzees’ routine health
examinations were studied. For all positive samples with parasite lineages belonging to the Laverania clade, the
complete mitochondrial genome (mtDNA), the gene encoding dihydrofolate reductase-thymidylate synthase
(dhfr-ts), the chloroquine resistance transporter (Pfcrt), the circumsporozoite protein (csp), merozoite surface protein
2 (msp2), and the DBL-1 domain from var2CSA were amplified, cloned, and sequenced. Other Plasmodium species
were included in the mtDNA, dhfr-ts, and csp analyses. Phylogenetic and evolutionary genetic analyses were
performed, including molecular clock analyses on the mtDNA.
Results/Conclusions: Nine chimpanzees were malaria positive (12.2%); four of those infections were identified as
P. falciparum, two as a Plasmodium reichenowi-like parasite or Plasmodium sp., one as Plasmodium gaboni, and two
as Plasmodium malariae. All P. falciparum isolates were resistant to chloroquine indicating that the chimpanzees
acquired such infections from humans in recent times. Such findings, however, are not sufficient for implicating
chimpanzees as an animal reservoir for P. falciparum.
Timing estimates support that the Laverania clade has co-existed with hominids for a long-period of time. The
proposed species P. gaboni, Plasmodium billbrayi, and Plasmodium billcollinsi are monophyletic groups supporting
that they are indeed different species.
An expanded CSP phylogeny is presented, including all the Laverania species and other malarial parasites.
Contrasting with other Plasmodium, the Laverania csp exhibits great conservation at the central tandem repeat
region. Msp2 and var2CSA, however, show extended recent polymorphism in P. falciparum that likely originated
after the P. reichenowi-P. falciparum split. The accumulation of such diversity may indicate adaptation to the human
host. These examples support the notion that comparative approaches among P. falciparum and its related species
will be of great value in understanding the evolution of proteins that are important in parasite invasion of the
human red blood cell, as well as those involved in malaria pathogenesis.
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Despite the extraordinary progress made in malaria control,
there are still 200 million clinical cases per year worldwide,
with more than 2.6 billion people living at risk of infection
[1,2]. Part of the challenge emerges from the fact that the
four Plasmodium species commonly found infecting
humans exhibit noticeable differences in their clinical mani-
festations, geographic distributions, and basic biological
characteristics [3]. Such differences are explained, at least in
part, by their independent origins as human parasites [4,5].
Indeed, phylogenetic studies have shown that host switches
have been common among primate malarial parasite
lineages and that they were important in the origin of
human malarias [6-13].
Without a doubt, primate malarial parasites have a
broader host range than previously suspected. Evidence
of host switches in modern times are found in the case
of the macaque parasite Plasmodium knowlesi infecting
humans in specific ecological settings [14,15] and the
cases of Plasmodium vivax-Plasmodium simium and
Plasmodium malariae-Plasmodium brasilianum that are
shared between humans and several species of New World
monkeys [12,16]. In addition, the human parasites P. vivax
and P. malariae have been found in African apes [9,17]. It
is worth noting that, whereas P. knowlesi is a zoonosis
transmitted from macaques [15], there is no data of mal-
aria transmission from non-human primates to humans in
the other cases [18].
The research community had previously known only
one species closely related to Plasmodium falciparum,
Plasmodium reichenowi found in chimpanzees [5,19-22].
However, the discovery of new Plasmodium lineages in
African apes that share recent common ancestors with
P. falciparum and P. reichenowi unveiled a more com-
plex evolutionary history [9-11,21-23]. Previous studies
on these African ape malarias have extensively discussed
the possibility of an animal reservoir for P. falciparum
malaria [9,11,18,22]. Whereas this is an issue of consid-
erable importance, it is not the only one. Indeed, the
value of these non-human falciparum-like parasites for
understanding the genetic diversity of P. falciparum has
not received adequate attention [19,20,24]. In this inves-
tigation, data from new isolates of Plasmodium spp.
found in chimpanzees (Pan troglodytes) are reported.
This expanded dataset allowed exploring the problem of
delimiting species in malarial parasites, as this issue
relates to the origin of P. falciparum. Then, those lineages
were used to investigate the evolution of three malarial
antigens: 1) the gene encoding the circumsporozoite
protein (CSP), a pre-erythrocytic malaria vaccine antigen;
2) the gene encoding MSP2, an erythrocytic stage malaria
vaccine antigen; and 3) the var2CSA gene that has been
associated with malaria in pregnancy. Overall, this study
reports long-term functional constrains in some of theseantigens (e.g. CSP), as well as patterns of high polymorph-
ism within P. falciparum that have a relatively recent
origin (msp2 and DBL-1 domain from var2CSA), bringing




The chimpanzees are housed at the Jane Goodall Institute’s
(JGI) Tchimpounga Chimpanzee Rehabilitation Center in
the Republic of Congo (RC). Blood samples were collected
throughout 2009-2010 by the veterinary staff as part of the
chimpanzees’ routine health examinations following stan-
dards approved by the Pan Africa Sanctuary Alliance. The
archived remainders of those blood draws were made avail-
able by JGI to Arizona State University (ASU) for malaria
diagnostics. The samples were exported by the JGI under
the RC CITES Export Permit No. 001 (Feb 2, 2010) and
imported by ASU under U.S. CITES Import Permit No.
09US094332/9. Other samples used in this investigation
were described elsewhere [9,13,25].
Genomic DNA was extracted from whole blood
(approximately 200 μl) using the QIAamp® DNA Blood
Mini kit (Qiagen, GmbH, Hilden, Germany) and each
sample was screened for Plasmodium parasites by nested
polymerase chain reaction (PCR), using primers for a
1200 bp fragment of the Cytochrome b (cytb) gene
[13,25]. Details about the protocols are shown in the
Additional files 1 and 2.
Species diversity and phylogenetic analyses
Approximately 5,800 bp of the parasites’ mitochondrial
genomes (mtDNA) and the gene encoding dihydrofolate
reductase-thymidylate synthase (dhfr-ts) were amplified
(Additional files 1 and 2). Independent alignments for
nucleotide sequences of the mtDNA and dhfr-ts gene were
made using ClustalX v2.0.12 and Muscle as implemented
in SeaView v4.3.5 with manual editing. A list of the species
included in phylogenetic analyses is provided in the
Additional file 3; information about the species such as
their basic biology, geographic distribution, and host-
range can be found elsewhere [3]. Phylogenetic relation-
ships were estimated using Maximum Likelihood (ML)
methods as implemented in PhyML v3.0 [26] and Bayesian
methods using MrBayes v3.1.2 [27].
In the case of the mtDNA, both phylogenetic methods
used a general time reversible + gamma model (GTR +G)
because it best fit the data as estimated by MEGA v5.0
[28]. The reliability of the nodes in the ML tree was
assessed by the bootstrap method with 200 pseudo-
replications. In the case of Bayesian analysis [27], each of
the three mitochondrial genes plus the non-coding regions
were used as separate partitions [25]. Bayesian support for
the nodes was inferred in MrBayes using 8 ×106 Markov
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was reached, the 50% of the sample as a burn-in was
discarded. Sampling was performed every 100 generations.
Convergence is reached after the average standard devi-
ation of the posterior probability is below 0.01 and the
value of the potential scale reduction factor (PSRF) is
between 1.00 and 1.02 [27]. In this analysis, all the lineages
reported elsewhere were also included (Additional file 3)
[9,13,25]. As a comparison, the genetic divergences in the
mtDNA among and within different Plasmodium species
were estimated using the Kimura 2-parameter model as
implemented in MEGA v5.
Similar procedures were followed when estimating the
phylogeny of dhfr-ts. A difference was that Bayesian
support for the nodes was inferred in MrBayes using 3
×106 Markov Chain Monte Carlo (MCMC) steps. In
the dhfr-ts analysis, sequences from different Plasmo-
dium species available in GenBank were also included
(see Additional file 4).
Estimation of divergence times
Time trees were estimated using BEAST v1.6 [29] on the
nucleotide mtDNA sequences (Additional file 3) using
four categories: each gene (cox1, cox3, cytb) plus the
non-coding regions as a separate partition. Relaxed clock
methods were applied with a GTR + G model of substi-
tution with heterogeneity among sites and in the four
partitions, optimizing the parameters specifically for
each of the partitions. Uniform distributions were used
as priors for the calibration intervals and the MCMC
was carried out until convergence and good-mixing of
the samples were reached [29]. Since time estimates are
sensitive to the assumptions and methods utilized
[13,25,30-35], the exploration of different scenarios is
always recommended [25]. In this investigation three
events were used as calibration points, one based on a
biogeographical landmark and two from fossils. The
scenarios explored, based on the calibration points
described in Additional file 1, were: (1) a combination of
the relaxed 6-14.2 Mya calibration for Papio-Macaca di-
vergence with the minimum of 20 Mya for the origin of
lemur parasites [30,31]; (2) a combination of the 6-14.2
Mya calibration with the two the minimums: 23.5 Mya
for the human/Macaca split [35] and 20 Mya; and (3)
the most conservative time period of 6-8 Mya narrowly
defined around the fossils of the Papio-Macaca diver-
gence [32,34] with a minimum of 20 Mya for the origin
of the lemur lineage [25].
Plasmodium falciparum chloroquine resistance transporter
In order to ascertain whether the P. falciparum strains
found in chimpanzees were acquired from humans, the
chloroquine resistance transporter (Pfcrt) was sequenced
so that mutations conferring resistance to the drug couldbe detected [36]. A fragment of approximately 250 bp
was amplified by PCR. This fragment contained all the
mutations that have been associated previously with
chloroquine resistance (C72S, M74I, N75(E/K) and
K76T) [36]. Details about the PCR protocol are provided
in the Additional files 1 and 2.
Malaria antigens
Circumsporozoite protein (CSP)
CSP is the predominant protein found on the surface of the
sporozoite [37-39], the haploid stage that is inoculated by
the mosquito vector into the vertebrate host. In this investi-
gation, the orthologous genes encoding the CSP protein in
malarial parasites from chimpanzees and other non-human
primate malarias were amplified (Additional files 1 and 2)
and compared against those sequences available in the
GenBank (see Additional file 4) [13,16]. The alignment of
csp sequences was done using only the N and C-terminal
regions since those can be accurately aligned [16], and the
phylogenetic relationships were estimated following the
methodology described for mtDNA with a general time
reversible + invariant model (GTR + I). Bayesian support for
the nodes was inferred in MrBayes using 2 ×106 Markov
Chain Monte Carlo (MCMC) steps.
Merozoite surface protein 2
Merozoite surface protein 2 (MSP2) is a highly abundant
GPI-anchored protein of P. falciparum that is found
exclusively in the Laverania clade [9,40-42]. The msp2
alleles found in the extant P. falciparum populations
have been grouped into two groups; so-called allele fam-
ilies 3D7 and FC27. Previous studies have suggested that
these allele families, like others such as msp1, are
maintained by balancing selection driven by the host
immune responses [42-44]. This investigation compared
the available msp2 alleles in the GenBank (Additional file
4) from the two families against orthologs found in
malarial parasites from chimpanzees (see Additional files
1 and 2). The alignment and phylogenetic analyses
followed the same methodology as above; however, the
data fitted a Hasegawa-Kishino-Yano + gamma model
(HKY + G) using MEGA v5.0 [28]. Bayesian support for
the nodes was inferred in MrBayes using 10 × 106
Markov Chain Monte Carlo (MCMC) steps.
Var2CSA protein
Pregnancy-associated malaria (PAM) is related to the
expression of a var gene, known as var2CSA [45-48].
Unlike others members of the var gene family, it is found
in all P. falciparum parasites isolates [49]. Here, approxi-
mately 1,500 bp (out of 10,000 bp) of the var2CSA gene
containing the complete Duffy binding-like 1 (DBL1) were
amplified from seven malaria chimpanzee isolates. The
PCR protocol and primers are described in the Additional
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sequences, obtained from chimpanzees and those available
in the GenBank (Additional file 4), was done using ClustalX
v2.0.12 and Muscle as implemented in SeaView v4.3.5 with
manual editing. The phylogenetic relationship among
DBL1 var2CSA alleles was estimated as explained above
with a general time reversible + gamma model (GTR+G).
In this case, Bayesian support for the nodes was inferred
using 20 ×106 MCMC steps.
The genetic polymorphism within each species (P. falcip-
arum and the non-falciparum chimpanzee lineages) was
studied by using the statistic π, which is the average num-
ber of substitutions per site between any two sequences. In
addition, in order to explore the putative effect of natural
selection, the average numbers of synonymous substitutions
per synonymous site (dS) and non-synonymous substitu-
tions per nonsynonymous site (dN) between a pair of
sequences were calculated using Nei and Gojobori’s method
[50] with the Jukes and Cantor correction. The difference
between dS and dN was estimated, and the standard devi-
ation was calculated using 1,000 pseudo-replications for dS
and dN, as well as a two tailed Z-test on the difference
between dS and dN also with 1000 bootstrap pseudo-
replications [51], as implemented in MEGA v5.0 [28]. The
null hypothesis was that dS = dN; or selectively neutral.
In addition, the mean (relative) evolutionary rate for
each amino acid residue on the same alignment of 918 bp
(306 aa) was estimated as implemented in MEGA v5.0
[28,51]. These rates were scaled such that the average evo-
lutionary rate across all sites is 1. This means that sites
showing a rate < 1 are evolving slower than average and
those with a rate > 1 are evolving faster. These relative
rates were estimated separating P. falciparum from
Plasmodium sp. using the Jones-Taylor-Thornton model
with a discrete Gamma +G distribution (4 categories).
The maximum likelihood estimate of the gamma shape
parameter was 0.3637 and the maximum Log likelihood
for this computation was−4,469.104.
GeneBank accession numbers published in this study
The sequences reported in this study were deposited in
GenBank under the following accession numbers: (1)
from JX893150 to JX893155 and KF040083 for mtDNA;
(2) from JX893156 to JX893168 for dhfr-ts genes; (3)
from JX899656 to JX899667 for csp genes; (4) from
JX899668 to JX899677 for the DBL1 var2CSA genes,
and (5) from JX893169 to JX893171, and JX899678 for
msp2 (see Additional file 4).
Results
Species diversity and phylogenetic analyses
Seventy-four chimpanzee (47 males and 27 females)
blood samples were screened for Plasmodium parasites.
Blood smears were collected, however, none of thesamples were positive by microscopy. Nine chimpanzees
were found positive (12.2%) by nested PCR using cyto-
chrome b (cytb); seven males (7/47 = 14.8%) and two
female (2/27 = 7.41%). Four of the nine positive samples
were identified as P. falciparum (isolates 11, 14, 22 and
30) using BLAST, one a mixed infection of P. reichenowi
and a Plasmodium reichenowi like parasite that will be
further referred as Plamodium sp. (isolate 20), one as
Plamodium sp. (isolate 70), one as P. gaboni (isolate 39),
and two as P. malariae (isolate 16 and 56). One of the
chimpanzees infected with Plamodium sp. was co-infected
with P. malariae (isolate 70). Seven parasites’ mitochon-
drial genomes were generated from these samples: four
P. falciparum, one P. reichenowi, one Plasmodium sp.
closely related to P. reichenowi, and one Plamodium
gaboni (Additional file 3). These new sequences were
analysed together with comparable data from African ape
malarias that were previously reported [9,21]; those in-
cluded P. gaboni and a so-called Plasmodium sp. parasite
lineage, as well as Plamodium billcollinsi and Plamodium
billbrayi. The clade that contains P. falciparum and P.
reichenowi and their sister lineages (P. gaboni, P. billbrayi,
P. billcollinsi and Plasmodium sp.) will be collectively
referred to as Laverania, a sub-genus used in classical
taxonomy for just the species P. falciparum and P.
reichenowi [52].
Genetic divergences among the mitochondrial genome
of the Plasmodium species found in chimpanzees are
shown in Table 1. As expected, the average genetic dis-
tance between the P. gaboni isolate sequence reported
here and the one previously reported (FJ895307) was just
0.003 ± 0.001 with a total of 18/5,800 differences between
the two isolates. This falls within the level of polymorph-
ism observed in recognizable species such as P. vivax and
P. falciparum. However, the average genetic distance
between P. billbrayi and P. gaboni (0.0181 ± 0.0015 for the
complete mtDNA, see Table 1), was comparable to the
divergence observed between P. vivax and Plasmodium
cynomolgi (0.0118 ± 0.0016, Table 1) and the one found
among rodent malarias [25,53]. Furthermore, the average
divergence estimated between the so-called Plasmodium
sp. and P. reichenowi lineages, as well as to P. billcollinsi
(see Table 1), were also comparable to those between well-
recognized Plasmodium species found in mammals
(Table 1).
Phylogenetic analyses were performed separately on the
complete mtDNA (Figure 1) and dhfr-ts gene (Figure 2).
Overall, both phylogenies were consistent, however, they
differ in where the root is placed by using Plasmodium
gallinaceum as an out-group. In the dhfr-ts phylogeny, the
Laverania clade seems to share a recent common ancestor
with rodent parasites. In both cases, maximum likelihood
and Bayesian methods yield comparable results, indicating
that the different Laverania lineages diverged following the
Table 1 Genetic divergences among different Plasmodium species
Genetic distance (d ± Std Err.)
Species n COX1 COX3 CYTB COX1 + CYTB complete mtDNA
P. vivax 110 0.001 ± 0.0005 0.001 ± 0.0005 0.000 ± 0.0001 0.001 ± 0.0003 0.001 ± 0.0001
P. vivax-P. cynomolgi 1 vs. 2 0.014 ± 0.0029 0.014 ± 0.0033 0.013 ± 0.0030 0.012 ± 0.0018 0.012 ± 0.0016
P. knowlesi 59 0.001 ± 0.0004 0.002 ± 0.0007 0.001 ± 0.0004 0.001 ± 0.0003 0.001 ± 0.0002
P. ovale wallikeri-P. ovale curtisi 2 0.011 ± 0.0030 0.025 ± 0.0056 0.013 ± 0.0031 0.012 ± 0.0022 0.012 ± 0.0014
P. chabaudi chabaudi 7 0.001 ± 0.0005 0.002 ± 0.0009 0.001 ± 0.0003 0.001 ± 0.0003 0.001 ± 0.0003
P. chabaudi adami 2 0.004 ± 0.0016 0.005 ± 0.0025 0.004 ± 0.0017 0.004 ± 0.0013 0.003 ± 0.0007
P. ch. chabaudi-P. ch. adami 7 vs. 2 0.005 ± 0.0017 0.009 ± 0.0028 0.006 ± 0.0019 0.005 ± 0.0013 0.005 ± 0.0007
P. billbrayi-P. gaboni 4 vs. 2 0.020 ± 0.0036 0.038 ± 0.0067 0.021 ± 0.0040 0.021 ± 0.0029 0.018 ± 0.0015
P. billbrayi-P. billcollinsi 4 vs. 1 0.103 ± 0.0088 0.167 ± 0.0150 0.086 ± 0.0096 0.095 ± 0.0063 0.077 ± 0.0039
P. reichenowi-Plasmodium sp.* 2 vs. 1 0.019 ± 0.0034 0.026 ± 0.0055 0.017 ± 0.0087 0.018 ± 0.0027 0.015 ± 0.0016
P. reichenowi-P. billcollinsi 2 vs. 1 0.076 ± 0.0076 0.130 ± 0.0158 0.039 ± 0.0063 0.060 ± 0.0048 0.051 ± 0.0028
P. reichenowi-P. falciparum (H) 2 vs.101 0.032 ± 0.0047 0.055 ± 0.0085 0.025 ± 0.0049 0.029 ± 0.0032 0.025 ± 0.0018
P. reichenowi-P. falciparum (Ch) 2 vs. 4 0.032 ± 0.0043 0.056 ± 0.0083 0.026 ± 0.0048 0.029 ± 0.0031 0.026 ± 0.0021
Plasmodium sp.*-P. falciparum (Ch) 1 vs. 4 0.036 ± 0.0052 0.060 ± 0.0091 0.034 ± 0.0056 0.035 ± 0.0034 0.030 ± 0.0022
P. falciparum (Ch)-P. billcollinsi 4 vs. 1 0.062 ± 0.0072 0.130 ± 0.0143 0.051 ± 0.0072 0.057 ± 0.0043 0.051 ± 0.0027
P. falciparum (Ch)-P. falciparum (H) 4 vs.101 0.000 ± 0.0000 0.001 ± 0.0007 0.001 ± 0.0005 0.001 ± 0.0002 0.002 ± 0.0004
P. falciparum (H) 101 0.000 ± 0.0001 0.001 ± 0.0004 0.001 ± 0.0003 0.000 ± 0.0001 0.000 ± 0.0001
*Sequence GeneBank accession number GQ355476.
(H) Human samples and (Ch) chimpanzee samples.
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cies (Figures 1 and 2). Plasmodium gaboni and P. billbrayi
form a monophyletic group that share a common ancestor
with the clade of P. falciparum-P. reichenowi (Figure 2).
Thus, both phylogenies reproduce almost identical evolu-
tionary histories and all the Laverania lineages reported
here. Furthermore, these lineages show divergences from
their closest sister taxa that are comparable to those
observed among well-established Plasmodium species.
Overall, these results are consistent with previous studies
that have identified multiple Plasmodium species in chim-
panzees [9-11,21].
Estimation of divergence times
The mtDNA phylogeny was used to estimate the time of
origin of the African ape parasites (Figure 3). Table 2
shows the divergence times of Plasmodium splits in the
Laverania clades as estimated by BEAST v1.6 [54] con-
sidering three different scenarios (see also Additional file
5 for the node numbers). As expected, the credibility
intervals obtained using these scenarios overlap (Table 2).
Under the first scenario, the estimates of the divergence
times for the radiation of African ape malarias suggest
that all five lineages might have originated between
13.09 and 22.93 million years ago (Mya); therefore,
African ape parasites may have started to diverge long
before the divergence of Pan and Homo (2.7-13.0 Mya)
[55,56]. The P. billbrayi-gaboni split is estimatedbetween 1.92-4.69 Mya and for P. reichenowi-P. falcip-
arum between 4.02 and 7.84 Mya. Those estimates are
older than those reported previously [9], but similar to
those times estimated by Pacheco et al. [13,25], using
fewer sequences but the same calibration points. How-
ever, regardless of the wide confidence interval, the time
frames for the reichenowi-falciparum split are still con-
sistent with the divergence of the genera Pan and Homo.
Overall, these time estimates suggest that the Laverania
species likely have been associated with hominids for a
long time [9,13,25].
Plasmodium falciparum chloroquine resistance transporter
The P. falciparum isolates found in the chimpanzees were
acquired recently from humans. The mtDNA genome
sequences clearly belong to P. falciparum [57] and all the
isolates had Pfcrt mutations (allele CVIET from Africa/
Southeast Asia) [36] associated with chloroquine resist-
ance. It is also worth noting that all the other Laverania
species lack those Pfcrt mutations associated with chloro-
quine resistance. This result was expected since those
species are not exposed to this anti-malarial drug.
Evolution of malaria antigens
Circumsporozoite protein
A phylogeny for the csp gene using the non-repetitive
regions is depicted in Figure 4. It follows the trend
evidenced by the mtDNA and dhfr-ts phylogenies in
Figure 1 (See legend on next page.)
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Figure 1 Phylogenetic tree of Plasmodium spp. based on complete mitochondrial genomes. Bayesian and Maximum Likelihood (ML) methods
yielded identical topologies, only the Bayesian tree is shown. The values above branches are posterior probabilities together with bootstrap values (in
bold) as a percentage obtained for the maximum likelihood tree (see methods). Human malaria parasites are labelled in red and the chimpanzee
identification is labelled in green. Branches indicated in green correspond to the African apes malarias, branches in blue correspond to the other
mammals Plasmodium parasites (rodents, lemurs, Asian primates, etc.), and black braches mean the out-group used in this study.
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dium sp. found in chimpanzees are part of a monophy-
letic group. However, there were differences in the
relationship of the major clades when the csp gene tree
was compared with the mtDNA and dhfr-ts phylogenies.Figure 2 Phylogenetic tree of Plasmodium spp. based on the gene en
yielded identical topologies, only the Bayesian tree is shown. The values ab
values (in bold) as a percentage obtained for the maximum likelihood tree
chimpanzee identification is labelled in green. * indicates a clade without sSince only the non-repetitive region can be properly
aligned [16], and not all phylogenetic analyses include
the same number of species, those differences are likely
the result of the limited phylogenetic information found
in relatively short sequences.coding dhfr-ts. Bayesian and Maximum Likelihood (ML) methods
ove branches are posterior probabilities together with bootstrap
(see methods). Human malaria parasites are labelled in red and the
upport in the maximum likelihood tree.
Figure 3 Timetree of the divergence of malarial parasites. Divergence times were estimated with BEAST using the most conservative
scenario based on the minimum divergence of Macaca and Papio using fossils (6-8 Mya) and a minimum of 20 Mya for the origin of lemur
parasites. Times are shown in millions of years ago (Mya).
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proteins exhibit extensive diversity in Plasmodium spe-
cies [13,37-39]. Such diversity is evidenced in the num-
ber of repeats within Plasmodium species and diverging
motifs, even among closely related species or within a
single species [13,16,37-39,58-61]. However, unlike other
malarial parasites [13,16,61], there is a strong conserva-
tion of the basic asparagine rich tandem motif among
the species in the Laverania clade (Table 3). Specifically,
the motifs PNAN and PNVD are present not only in P.
falciparum [44,62], but also in all Laverania species.There are, however, a few differences. The motif PNVN is
only found in P. reichenowi and Plasmodium sp. but not
in P. falciparum. Likewise PNAD, a motif found in low
number in P. billcollinsi, P. billbrayi, and P. gaboni is not
present in P. falciparum [44,62]. Finally, two different as-
paragine rich motifs could be identified in P. billcollinsi;
(PNANPN)17 and the less common (PNANPNPN)2. The
frequency of the repeats appears in Table 3. Interestingly,
Plasmodium yoelii and P. billcollinsi are the only species
with repeats between the regions identified as Pf1 and Pf2
(Figure 5, Table 3) that can bind heparin/heparin sulphate
Table 2 Divergence times of Plasmodium splits in the Laverania clade as estimated by BEAST
Calibrations (Mya) Node 13: 6-14.2 Node 13: 6-14.2 Node 13: 6-8
Node 14: min = 23.5
Node 19: min 20 Node 19: min 20 Node 19: min 20









34 17.49 13.09-22.93 18.23 13.73-23.72 15.55 12.07-19.75
Split P. billbrayi-P.
gaboni




33 11.98 8.73-16.17 12.48 8.97-16.63 10.63 7.85-13.79
Split Plasmodium
sp.-P. reichenowi
31 2.75 1.80-3.97 2.84 1.84-4.08 2.41 1.53-3.41
Split P. reichenowi-
P. falciparum
32 5.71 4.02-7.84 5.93 4.12-8.04 5.03 3.52-6.70
Radiation of Southerm
Asia primates malaria
11 6.47 5.09-8.28 6.76 5.24-8.40 5.5 4.50-6.88
Radiation of rodents
malaria
25 13.84 9.91-18.09 14.39 10.72-18.83 12.28 9.16-15.80
Radiation of Plasmodium
in mammals
35 38.74 31.80-48.18 40.56 33.90-49.13 35.12 30.24-40.79
The node numbers are shown in the Additional file 5.
Figure 4 Bayesian phylogenetic tree of chimpanzee Plasmodium based on the csp gene. The values above branches are posterior
probabilities (see methods). Human malaria parasites are labelled in red and the chimpanzee identification is labelled in green.
Pacheco et al. Malaria Journal 2013, 12:328 Page 9 of 20
http://www.malariajournal.com/content/12/1/328
Table 3 CSP repetitive motifs and the polymorphism found in all Laverania species analyzed
Species NCBI No. Repeat motifs π dS-dN (SE) /
p (ZTest)
Repeat motif combination
P. billcollinsi JX899657 R1: [DDANN]3 0.040 (0.039) −0.050 (0.049) 0.248
(1.161) dS = dN
Pf1-[1]3[2]3–Pf2–[3]24[3]44[3]3
4[3]55[3]35-PNR2: [DNANN]3
R3: [PNANPN]17 0.078 (0.045) 0.470 ± 0.224 0.017
(−2.431) dS > dN
R4: [PNAD]3
R5: [PNANPNPN]2
P. billbrayi JX899659 R4: [PNAD]4 0.104 (0.053) 0.315 ± 0.203 0.023
(−2.298) dS > dN
Pf2—4[6]24[6]64[6]64[6]15-PN
R6: [PNAN]29
P. gaboni JX899661 R4: [PNAD]2 0.128 (0.058) 0.347 ± 0.246 0.021




P. reichenowi R6: [PNAN]26 0.164 (0.063) 0.211 ± 0.231 0.014
















JX899664 R6: [PNAN]36 0.131 (0.047) 0.224 ± 0.149 0.002















PN are amino acids located at the end of the repetitive region. Pf1 and Pf2 are peptides described by Ancsin and Kisilevsky 2004 [63].
Pacheco et al. Malaria Journal 2013, 12:328 Page 10 of 20
http://www.malariajournal.com/content/12/1/328binding sites (see below). In the case of P. billcollinsi, the
repeat also involves an asparagine rich motif.
The alignment of the N and C-terminal domains of the
csp gene is illustrated in Figures 5 and 6, respectively, in-
corporating information about functionally relevant parts
of the protein [37,63,64]. The signal peptides (Figure 5)
were predicted using the SignalP 4.0 Server [65]. The CS
proteins from P. billcollinsi, P. gaboni, P. billrayi, and P.
reichenowi show differences in a region of low complexity
that is found prior to the so-called region I (see Figure 5).
The region I (KLKQP) [64,66], contained in Pf2 [63], is a
protease cleavage site that plays a critical role in the pro-
cessing of the CS protein in the mammalian host and
exhibits high affinity to heparin sulphate found on the
surface of liver cells or hepatocytes [37,38,63,64,66]. The
motif KLKQP is conserved between P. reichenowi and P.falciparum, as is the case in many of the other Plasmo-
dium species. However, three of the Laverania lineages
differ, having the variant KLRQP instead of KLKQP,
(specifically P. billcollinsi (Pbillc), P. billbrayi (Pbillb), and
P. gaboni (Pgab)) (Figure 5). Previously, the only known
CSP sequences with variations in this region were the
avian parasite P. gallinaceum, with the motif NLNQP,
and the rodent parasite P. yoelii, with KLNQP [66,67].
Surprisingly, the two African Cercopithecidae parasites, P.
gonderi (identified as Pgo in Figures 5 and 6) and the one
from mandrills (Pmn) lack the region I (KLKQP). These
results were reproduced not only by independent PCRs,
but also by a perfect match in Plasmodium gonderi gen-
omic data [68].
The other two regions in the CSP with capacity to
bind heparin/heparin sulphate (HS) [63,64], in addition
Figure 5 Alignment of the N-terminal region for orthologous genes that encode CS protein in different Plasmodium spp. Functional
regions are described elsewhere [63,64]. The species names are abbreviated as follow: Pvi-P. vivax (Thai), Pcy-P. cynomolgi (Gombak), Pin-P. inui
(Hawking), Por-Plasmodium sp. from orangutans (VS28), Phy-P. hylobati, Pco, P. coatneyi, Pkn-P. knowlesi, Pfr-P. fragile, Pmn-Plasmodium sp. from
mandrill, Pgo-P. gonderi, Pma-P. malariae, Pbe-P. berghei, Pyo-P. yoelli, Pbillc-P. billcollinsi, Pbillb-P. billbrayi, Pga-P. gaboni, Psp-Plasmodium sp.,
PreA-P. reichenowi (Sanger), PreB-P. reichenowi from chimp 20, Pf-ch-P. falciparum from chimp 22, Pf3D7-P. falciparum strain 3D7, and Pgall-P.
gallinaceum.
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and one in the C-terminal domain or Pf4-Region II+, see
Figure 5 and 6 [37,38,63,64,66]. Pf1 is not considered
critical [63] and is not conserved in P. vivax and related
parasites [5,6], however, it is highly conserved among
Laverania and the only avian CS protein sequence avail-
able [67] setting them apart from the other Plasmodium
found in mammals (Figure 5). The Pf4 with the so-called
region II + [63,64] (Figure 6) is conserved among Plasmo-
dium species and almost identical in the Laverania clade
(EWSPCSVTCGNGIQVRIK) with few synonymous sub-
stitutions (dS = 0.1504 vs. dN = 0.0). The CS.T3, a T-cell
epitope responsible for a CD4+ T-cell response that corre-
lates with protection [64], is also identical among P. falcip-
arum and the Plasmodium species from chimpanzees
(Figure 6). Thus, with the exception of the specific
changes described above, the CS in Laverania is highly
conserved, including the observed motifs in the tandem
repeat region, the latest contrast with other Plasmodium
spp. found in mammals. [13,16,61,67].
Merozoite surface protein 2
The two msp2 allele families in P. falciparum are almost
identical at nucleotide sites encoding the N and Ctermini [42], but they differ in a central low complexity
region that clearly separates the two allele families into
the so-called 3D7 and FC27 types, named after the
strains from which they were originally sequenced [69].
It has been proposed that these two allele families origi-
nated after the P. reichenowi-P. falciparum split [44,70].
One line of evidence for this came from the so-called
repeat homology regions or RHRs [44,70], where re-
peats observed in P. reichenowi showed similarities with
one allele family or the other. Figure 7 depicts the
amino acid alignment of the msp2 allele families and the
new sequences of P. reichenowi (isolate 20, mixed infec-
tion) and Plasmodium sp. (isolates Shegue and 20) para-
sites; these four were the only complete sequences
obtained in this investigation. Plasmodium reichenowi
shares with the 3D7 the so-called RHR1 marked in
yellow [44] but it was not found in the Plasmodium sp.
parasite or in the FC27 family. Attempts were made to
identify the second RHR [44,70] (in blue) that is shared
among P. reichenowi and P. falciparum. However, the
patterns do not seem clear and whether it is actually
homologous was difficult to determine. A conserved
motif (in pink) is shared between FC27 alleles and
P. reichenowi.
Figure 6 Alignment of the C-terminal region for orthologous genes that encode CS protein in different Plasmodium spp. Functional
regions are described elsewhere [63,64]. The species names are abbreviated as follow: Pvi-P. vivax (Thai), Pcy-P. cynomolgi (Gombak), Pin-P. inui
(Hawking), Por-Plasmodium sp. from orangutans (VS28), Phy-P. hylobati, Pco, P. coatneyi, Pkn-P. knowlesi, Pfr-P. fragile, Pmn-Plasmodium sp. from
mandrill, Pgo-P. gonderi, Pma-P. malariae, Pbe-P. berghei, Pyo-P. yoelli, Pbillc-P. billcollinsi, Pbillb-P. billbrayi, Pga-P. gaboni, Psp-Plasmodium sp.,
PreA-P. reichenowi (Sanger), PreB-P. reichenowi from chimp 20, Pf-ch-P. falciparum from chimp 22, Pf3D7-P. falciparum strain 3D7, and Pgall-P.
gallinaceum.
Pacheco et al. Malaria Journal 2013, 12:328 Page 12 of 20
http://www.malariajournal.com/content/12/1/328The second line of evidence comes from the conserved
flanking regions (Block 1 and 5 sensu [42]) where P.
reichenowi seems separated from the two-allele families.
However, no formal phylogenetic analyses were performed.
Here a phylogeny of the newly sequenced msp2 from chim-
panzee parasites together with all complete P. falciparum
msp2 sequences was inferred (Figure 8). The chimpanzee
lineages are different from the two-allele families. Indeed
the P. reichenowi and the Plasmodium sp. alleles form a
monophyletic group clearly different from the two P. falcip-
arum allele families. Given the host switches observed, the
time of origin for these two families cannot be estimated by
assuming that P. reichenowi and P. falciparum diverged
with their host as previously done [42].
Evolution of the var2CSA DBL1 domain
The var2CSA DBL1 domain was not successfully amplified
from the all the chimpanzee isolates; however, data was
obtained from P. billbrayi, P. gaboni, the Plasmodium sp.
lineage, P. reichenowi and three of the P. falciparum para-
sites. A Bayesian phylogeny is depicted in Figure 9; it
includes all the sequences obtained in this investigation
together with those available at the GenBank. As expected,the P. falciparum parasites found in chimpanzees clearly
group within the known sequences from human infections.
Although there are different malarial parasites present in
chimpanzees, the var2CSA sequences did not show much
divergence among them. In some cases, there is an appar-
ent gene duplication as evidenced by the two sequences
obtained from some of the isolates, e.g. the isolates that
yield P. gaboni mtDNA (isolate 39) and Plasmodium sp.
(isolate 70) (Figure 9). Nevertheless, given that these are
field isolates, there is still the possibility of mixed infections
even when those were no detected using other genes.
Table 4 shows estimates of the genetic diversity for the
alleles reported here. The diversity of the DBL1 domain
from var2CSA DBL1 in chimpanzees, even when all the
sequences are considered as one “species”, was lower
than the diversity found in P. falciparum (0.0939 ±
0.0062 vs. 0.1173 ± 0.0064 respectively). It is also worth
noting that in almost all comparisons there were signifi-
cantly more synonymous than non-synonymous substi-
tutions (Table 4) suggesting functional constraint. The
diversity within P. falciparum and those lineages found in
chimpanzees was further explored using codon-based
analyses. Figure 10 shows the evolutionary rate per codon.
Figure 7 Alignment of the N and C-terminal region for orthologous genes that encode MSP2 in the Laverania species. The repeat
homology regions 1 or RHR1 described by Rich and Ayala 2000 [44] are shown in yellow.
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many P. falciparum codons (in blue) vary more than in the
chimpanzee lineages (in red) (Figure 10). Overall, the
results indicate that there is extensive variation within P.
falciparum that is not observed among distinct ape malaria
lineages. Thus, like in msp2, such divergence seems to be
originated after the P. falciparum-P. reichenowi split.Discussion
Defining Plasmodium species
The molecular evidence indicates that there are several
species within the Laverania clade. These lineages have
been independently reported [9-11,21] indicating that
they are actively transmitted. Regardless of the absence
of morphological evidence, these are well-defined phylo-
genetic species since they show a level of divergence
comparable with those observed between related taxa
such as P. vivax and Plamodium cynomolgi. The use of
molecular methods for defining species in malarialparasites is not free of controversy [71], however, such
debates are not new in biology [72].
There are several considerations favouring the use of
molecular criteria to delimit species in Plasmodium.
First, several infections appear to be sub-microscopic
making the use of morphological evidence difficult if not
impossible, in many cases. Second, in the case of
Laverania parasites, whenever blood stages have been
observed, they seem to be indistinguishable from P.
falciparum [3,21,73]. Such limitations on the use of mor-
phological traits are relatively common in malarial para-
sites. For example, trained microscopists could not
detect P. knowlesi when observed in humans and mis-
identified these zoonotic infections as P. malariae or P.
falciparum [14,74]. Furthermore, there is clear genetic
divergence in the mtDNA among parasites morphologic-
ally identified as Plamodium relictum in birds [75,76].
Finally, there are many non-human primates that are en-
dangered species, so studies on parasite biodiversity
likely will use opportunistic samples that may only allow
Figure 8 Bayesian phylogenetic tree of the Laverania Plasmodium species based on the msp2 gene. The values above branches are
posterior probabilities (see methods). The two groups that are called allele families, 3D7 (in red) and FC27 (in blue) are shown.
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ing that unlike malarial parasites in Asian apes or lemurs
[3,13,25,52,73], there were not multiple P. falciparum-
like morphologically described species in African apes.
The only recognized species was P. reichenowi [3,52,73], a
parasite from which there is molecular data, and these
lineages are related, but clearly not the same parasite
[9-11,21,22]. Thus, it is not necessary to establish whether
these new species correspond with others previously
described. Overall, the DNA evidence allows a stable
taxonomy that facilitates comparisons among studies.
Separate discussions are what is considered a level of
divergence that could indicate different species or sub-
species [22,25,53,76,77] and what kind of genetic data
should be used. For example, the use of 400-600 bp seg-
ments of the mitochondrial gene cytb, as has been widely
used in avian malaria studies, seems insufficient. How-
ever, a suitable fragment of the mtDNA that includes
the cytb and cox1 [10] provides valuable phylogenetic
signal that is consistent with the complete mtDNA and
other genes [5,10,13,25]. In the context of this investiga-
tion, P. gaboni and P. billbrayi are a good case study
[22]. The available evidence, at least at the level of
complete mtDNA sequences, indicates that the diver-
gence between P. gaboni and P. billrayi is comparable to
that between P. vivax and P. cynomolgi. Accordingly, if
P. billbrayi were considered a synonymy of P. gaboni,
and consequently studied as part of a single taxon, thenthe observed mtDNA “polymorphism” would exceed
that found within any other known Plasmodium species
with worldwide distributions (Table 1). Such pattern will
require an ad hoc explanation that cannot be supported
on what is known about the mitochondrial genome
diversity in Plasmodium. Thus, it seems more parsimo-
nious to hypothesize the existence of two different
species, rather than explaining how such a high level of
polymorphism can be harboured within one species. The
P. gaboni-P. billbrayi separation is supported by the dhfr
and csp genes but some of those differences are hard to in-
terpret in the absence of mtDNA data (e.g. differences in
low complexity regions in the csp, see Figure 5). However,
taking together the observed differences in the dhfr and
csp genes and the mtDNA divergence, a recent but clear
divergence between P. gaboni and P. billbrayi was found.
Thus, the hypothesis that these two evolutionary lineages
are different species seems to hold.
Likewise, the so-called Plasmodium sp. appears to be a
distinct lineage that is closely related to P. reichenowi;
whether these are species or sub-species require some
additional considerations. The Plasmodium sp. lineage
corresponds with mitochondrial haplotypes identified as
P. reichenowi that were previously isolated from chim-
panzees in the same region and reported as part of clade
C1 [10], as well as with a previous study using complete
mtDNA [9]. The differences in terms of the csp and the
var2CSA are mostly qualitative and difficult to interpret.
Figure 9 Bayesian phylogenetic tree of the Laverania Plasmodium species based on the var2CSA DBL1 gene. The values above branches
are posterior probabilities (see methods).
Table 4 Polymorphism found in var2CSA DBL1 gene sequences from P. falciparum and chimpanzee malarial parasites
VAR2CSA-DBL1
Species π (SD.) Ds Dn Ds-Dn (SD.) p (Z-stat)
P. falciparum (Human, N = 21) 0.1173 (0.0064) 0.1674 0.1200 0.0471 (0.0186) 0.0227 (−2.3078) Ds > Dn
P. falciparum (Human-Chimp, N = 24) 0.1146 (0.0066) 0.1641 0.1171 0.0470 (0.0209) 0.0207 (−2.3449) Ds > Dn
Chimpanzee malaria (all Chimp, N = 8) 0.0939 (0.0062) 0.1424 0.0914 0.0509 (0.0206) 0.0087 (−2.6660) Ds > Dn
Chimpanzee malaria (Chimp-Clade A, N = 2) 0.0122 (0.0035) 0.0360 0.0069 0.0291 (0.0145) 0.0464 (−2.0124) Ds > Dn
Chimpanzee malaria (Chimp-Clade B, N = 6) 0.0895 (0.0065) 0.1240 0.0893 0.0347 (0.0188) 0.0797 (−1.7670) Ds = Dn
Clade A and B are shown in Figure 9.
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Figure 10 Mean (relative) evolutionary rates for the VAR2CSA protein. These rates are scaled such that the average evolutionary rate across
all sites is 1. This means that sites showing a rate < 1 are evolving slower than average and those with a rate > 1 are evolving faster than average.
These relative rates were estimated under the Jones-Taylor-Thornton model (+G). A discrete Gamma (+G) distribution was used to model
evolutionary rate differences among sites (4 categories). Blue dots correspond with P. falciparum and red dots are chimpanzee parasites. The
graph shows that P. falciparum sequences are by far more divergent that those lineages found in chimpanzees.
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from Plasmodium sp. by only 11 SNPs (d = 0.007 versus
d = 0.016 between P. reichenowi and P. falciparum using
Kimura 2-parameter). This difference is hard to interpret
since this gene is seldom sequenced in non-human pri-
mates so we lack a good database for comparison.
Although the msp2 actually separates these two lineages
(P. reichenowi from Plasmodium sp.) in terms of its low
complexity regions and SNPs in the 3′ and 5′ termini, it is
an antigen under balancing selection [42]. Nevertheless,
the differences on dhfr and msp2 establish a linkage be-
tween nuclear and mitochondrial genes [77] suggesting
that these two lineages are at least different sub-species.
The divergence of these two P. reichenowi s.l. lineages
seems to be the result, at least in part, of the geographic
differentiation of the host populations (P. troglodytes) [10].
However, in order to set a high standard, additional data is
needed in order to determine whether these should be
considered sub-species or species. The reference mito-
chondrial haplotypes for this lineage called as Plasmodium
sp. in this investigation are identified with the accession
numbers GQ355476 and KF040083. At this point, it is
worth noting that identifying species or sub-species is not
only of taxonomic interest. Indeed, using “pooled data”
from otherwise different species could affect comparative
analyses aiming to ascertain the processes shaping the
genetic diversity of P. falciparum. Furthermore, having
delimited molecular lineages is epidemiologically criticalin determining whether or not apes are a reservoir for
P. falciparum [18].
Apes as potential reservoirs for human malarias
The finding of chloroquine resistant P. falciparum in
chimpanzees provides evidence of a host switch from
humans at a time scale that is epidemiologically relevant.
However, whether this indicates that chimpanzees could
act as malaria reservoirs is a different matter. Indeed,
there are several criteria that need to be fulfilled, such as
evidence that apes can sustain P. falciparum infections
and produce gametocytes [73,78], as well as understand-
ing the ecological factors that may allow vectors to feed
on apes and humans. It is worth noting that P. falcip-
arum does not yield high parasitemias at least in chim-
panzees [73,78], so it may be possible that the same
phenomenon happens in gorillas. Thus, there is no evi-
dence that currently confirms or categorically rules out
apes as reservoirs for P. falciparum.
Evolution of gene encoding malarial antigens
This investigation shows how ape malarias provide new
insights on the evolution of important antigens. In the
case of the CS protein, unlike other Plasmodium from
mammals [13,16,59,61], the central tandem repeat region
is conserved among the Laverania lineages. Whether this
pattern is the result of immune pressures or functional
constrains [62] from genomes with a trend toward
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[79], are issues that will require additional studies. An-
other observation is the conservation of peptides binding
heparin sulphate (HS). Specifically, the two cell surface
receptors involved in the sporozoite attachment to the
hepatocytes (highly sulphated HS associated with region
I + or Pf2 and Pf4 region II +, see Figure 1 [63,64]) are
almost identical among the Laverania lineages. These
similarities suggest that the Laverania sporozoites can
bind comparable receptors in the human and apes livers
[59] providing additional support to the observation that
these parasites can potentially infect several species of
hominids.
Although Laverania parasites are the scope of this
study, the lack of region I in Plamodium gonderi and the
Plasmodium spp. should be highlighted. These are the
only known Plasmodium species with a CS protein miss-
ing this functionally important region [16,38,63]. In the
absence of additional information, any interpretation is
speculative. However, this CS protein “natural knockout”
of the region I (see [38,66]) suggests that these parasites
may have some unique processing of their CS proteins
and may provide new insights on the Plasmodium inva-
sion of the liver.
Regarding the msp2, it has been proposed that these
two major groups of alleles (also referred as allele fam-
ilies) originated soon after the P. reichenowi-P. falcip-
arum split [42,44,70]. This contrasts with the allele
families in msp1 that are considered an old polymorph-
ism [43]. The data presented here indicates that the
diversity of msp2 alleles observed in P. falciparum origi-
nated after the P. falciparum-P. reichenowi split. This
hypothesis was originally proposed by the discovery of
the so-called mosaic structure of P. reichenowi MSP2
[44,70], however, it was still possible that additional data
from other Laverania species could provide evidence of
an older polymorphism in msp2. Indeed, some motifs
are conserved among the different allele families, and P.
reichenowi and Plasmodium sp. parasites (Figure 7),
suggesting that such convergence/recombination events
predate the P. reichenowi-P. falciparum divergence.
Here, a phylogeny (Figure 8) shows that the two-allele
families are part of a monophyletic group separated from
the chimpanzee parasites. Considering that msp2 is only
found in the Laverania clade, the fast divergence of these
two alleles families may had been driven by allele-
specific immunity [41,80] that could lead to a pattern
consistent with balancing selection [42]. Recent high
genetic diversity within extant P. falciparum populations
seems to be also the case for var2CSA.
As described earlier, var2CSA is critical in pregnancy-
associated malaria and is one of the few members of the
var gene family that is found in all P. falciparum isolates
[45-47]. This preliminary study shows that var2CSA canbe found in relatively divergent Laverania lineages
(Figure 9). Considering the fact that other var genes are
seldom shared among even P. falciparum isolates [48,49],
this observation reinforces the importance that this par-
ticular var gene has in P. falciparum and the other species
of the Laverania clade. The second observation that
emerges is that var2CSA accumulated extraordinary
genetic polymorphism after the P. reichenowi and P.
falciparum split. Whereas these observations should be
considered preliminary, lineages that are highly divergent
in the mtDNA (e.g. P. gaboni) show relatively low diver-
gence in the DBL1 var2CSA. The results presented here
also indicated that it is possible that var2CSA is duplicated
in some chimpanzee lineages, a phenomenon that has
been observed in some P. falciparum strains (e.g. HB3, see
Figure 9). Taken together, this study shows that the
presence of var2CSA is relatively “ancient” (e.g. shared
between ape lineages and humans), a situation contrasting
that seen with other var genes [49]. This indicates some
functional importance for this var2CSA gene. Such
evidence allows hypothesizing that natural selection has
maintained this var gene in the Laverania group; thus, it
should confer some adaptive advantage for the parasite. If
acquired immunity that results from malaria exposure
affects transmission in humans (parasite fitness), then
var2CSA may increase the parasite transmissibility in a
second segment of the population that otherwise will be
immune, such as primigravid women. Unfortunately, there
is no information on gametocytaemia in primigravid
women or whether parasite transmissibility increases for
that malaria high risk group. Thus, in the absence of such
data, this hypothesis of a selective advantage for var2CSA
cannot be formally tested.
Conclusions
The Laverania clade consists of a highly diverse group of
species. All the species described are actively transmit-
ted; evidence of this is that they have been independ-
ently found in different studies. Thus, they are stable
evolutionary and ecological units as expected for any
Plasmodium species. This investigation provides add-
itional evidence that chimpanzees can acquire P. falcip-
arum from humans. However, whether they can sustain
transmission and act as a reservoir is a matter that
requires additional studies.
This study emphasizes the value of comparative stud-
ies on genes involved in the infection of humans by mal-
arial parasites. Such studies improve our understanding
of the molecular bases of these parasites pathogenesis
and provide information on the rate and mode of evolu-
tion of antigens that are considered vaccine targets. As
specific examples, this investigation provides evidence of
constraints in the evolution of the CS protein among the
Laverania species that have not been observed in other
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tandem repeat region. In contrast, antigens such as
MSP2 and VAR2CSA likely accumulated genetic vari-
ation very recently, suggesting the role of natural selec-
tion and highlighting their importance as adaptations to
the human host.
Studying the evolution of the P. falciparum clade will
require an extensive sampling of parasites from African
apes; sampling that is difficult due to ethical concerns
and regulations limiting research on apes. In addition,
collecting viable isolates of these falciparum-like para-
sites in order to use them for comparative studies may
prove to be even more complex. Nevertheless, it is
worthwhile to consider such studies if they will not
expose African apes to any significant risk.
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mtDNA: Mitochondrial genomes; PAM: Pregnancy-associated malaria;
PCR: Nested polymerase chain reaction; PfCRT: Chloroquine resistance
transporter; PSRF: Potential scale reduction factor.
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